Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03870633 · ClinicalTrials.gov registry record

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
521
Enrollment target

NCT03870633 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 521 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03870633 has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
521 participants
Enrollment target

Study Summary

This trial studies financial difficulty in participants with chronic lymphocytic leukemia and multiple myeloma. Assessment of financial difficulty may help to better understand the financial impact of cancer and come up with ways to help participants avoid financial problems during treatment.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Medical Chart Review
  • OTHER Interview
  • OTHER Questionnaire

Trial Details

FieldValue
Enrollment Target 521 participants
Start Date 2019-05-14
Est. Completion 2023-05-01

What the Registry Record Tells You About NCT03870633

The ClinicalTrials.gov registry entry for NCT03870633 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 521 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.

NCT03870633 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03870633 about?

NCT03870633 is a clinical study titled "Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma". This trial studies financial difficulty in participants with chronic lymphocytic leukemia and multiple myeloma. Assessment of financial difficulty may help to better understand the financial impact of cancer and come up with ways to help participants avoid financial problems during treatment.

What is the current status of trial NCT03870633?

This trial is currently completed. The enrollment target is 521 participants. The study started on 2019-05-14. Estimated completion is 2023-05-01.

What interventions are being tested in trial NCT03870633?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Medical Chart Review (OTHER), Interview (OTHER), Questionnaire (OTHER).

Who is sponsoring clinical trial NCT03870633?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.